NDC properties for "Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count)" (RxCUI 2640901)
About this data
The tables show NDC propoerties for Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count) with the RxCUI 2640901
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count) (RxCUI 2640901)
BLA | BLA761058 |
---|---|
MMSL_CODE | BD32554 |
RxCUI | 2640901 |
SPL_SET_ID | 115ea79b-7209-7f19-b35d-36ec0828fbf5 |
Prescribable Synonym | CYLTEZO Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count) |
RXNAV_STR | Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count) |
RxNorm Name | {4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector [Cyltezo]) } Pack [Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis] |
RxNorm Synonym | Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count) |
Related queries | Interactions (for RxCUI 2640901) |
NDC Properties
NDC Item 00597037523
NDC 9 | 0597-0375 |
---|---|
NDC 10 | 0597-0375-23 |
NDC Item | 00597037523 |
Packaging | 4 KIT in 1 CARTON (0597-0375-23) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
BLA | BLA761058 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0375 |